SOX2 was the most upregulated TF (Boumahdi et al., 2014) in cancer stem cells from skin squamous cell carcinoma (SCC) and was shown to control self-renewal (Sastre-Perona et al., 2019). This evidence concerns the gene SOX2 and cancer.